{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6m5LsLDA","lastupdate":"2024-11-18T00:00:00.000Z","update_date":"2024-11-18T00:00:00.000Z","lastModified":"Nov 18, 2024","active":1,"confidence_score":98,"confidence_score_reason":"markets","urlname":"mileutis","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$E2p8OmkpCPmqBabYQNdLs9XcYBCvK1Hzsdu4cShUW8O2kqsJIHwb3X","name":"Mileutis","oneliner":"Bio-pharmaceuticals for Animal and Human Health","registrar":"513504977","website":"https://mileutis.com","careerspage":"https://mileutis.com/career","founded_month":1,"founded_year":2004,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/28138649","instagram":""},"social":["https://www.linkedin.com/company/28138649"],"flattenedsociallinks":"https://www.linkedin.com/company/28138649","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":32,"patent":1,"raised":20000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual-free therapies for animal and human health.\n\nMileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.\n\nThe company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows.  Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97286873817","country":null,"address":{"israeli":[{"id":"0784e11b-5a67-4094-8ebf-61ba8d07885f","city":"Ness Ziona","type":null,"address":"Golda Me'ir Street 7, Ness Ziona, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"URxm4o0WUhAtCmJbudwYHA8YuGsBlyB1PQ2A5CxZtVOoA0Yo38ZpF7","date":"May 28, 2024","link":"https://www.prnewswire.com/il/news-releases/yotvata-dairy-farm-invests-in-mileutis-to-improve-milk-quality-302156593.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"sustainability","company":"Mileutis","layoffs":null,"summary":"Mileutis, an Israeli biopharmaceutical company, has announced a significant investment and expanded collaboration with Yotvata Dairy. This partnership aims to redefine the dairy industry by implementing a cutting-edge management system that reduces antibiotic use, enhances milk quality, and boosts sustainability. Yotvata Dairy Farm will invest millions of New Israeli Shekels in Mileutis, supporting the use of Imilac™ therapy to replace antibiotics in dairy farms. The collaboration follows successful clinical trials demonstrating Imilac™s effectiveness in improving milk yield and quality while reducing greenhouse gas emissions. This initiative aligns with the broader industry goal of achieving carbon neutrality by 2050. The partnership is expected to generate significant revenue and represents a major step towards more sustainable dairy farming practices.","partners":"Yotvata Dairy","customers":null,"investors":"Yotvata Dairy","confidence":9,"key_topics":["sustainability","antibiotics","dairy farming","milk quality","greenhouse gases"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"millions of New Israeli Shekels","structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2PvB1zZicVS8PwJoTySzLP1ViFQJrtvH2lCZghwr4VmsNwzG0s3Ev6","news_summary":"Yotvata Dairy Farm Invests in Mileutis to Improve Milk Quality","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"lUYu35awombRrhvJIQu0PwwPYiBFFE1Mgt2ocWua8kInNwQk52iuVZ","date":"Aug 11, 2023","link":"https://www.claytoncountyregister.com/news2/startup-says-antibiotic-free-therapy-for-cows-yields-better-milk/76755/","source":"www.claytoncountyregister.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"TqAmAimM5F159T1hz0jXb1xdJHn4yYSPEmkyWqwcYUmnabi9TEi7cv","news_summary":"Israeli Startup Mileutis Finds Antibiotic Replacement for Dairy Industry","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"j2FoWFqCoaKuKbnpePkG9vj3UOq9ciqJKMukUzvch18fVyhhWqm5fq","date":"Aug 8, 2023","link":"https://www.reuters.com/business/healthcare-pharmaceuticals/israels-mileutis-trial-shows-better-milk-quality-without-antibiotics-cows-2023-08-08/","source":"www.reuters.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"aZYltPrgTyhejn6adF3068YPqv742PyMgxAb6pEOVhJJ5jNZrkis2D","news_summary":"Israel's Mileutis trial shows better milk quality without antibiotics in cows\n","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"8RCbfKhNWlmcl2wVXaixUvjAiMcyQmg0dMiLn5Ge5azzXhITvJNmQV","date":"Aug 7, 2023","link":"https://www.startuphub.ai/mileutis-clinical-trial-achieves-dramatic-reduction-in-antibiotic-use-and-enhanced-milk-quality-in-dairy-cows/","source":"www.startuphub.ai","visible":1,"analysis":{"tags":"sustainability","company":"Mileutis","layoffs":null,"summary":"Mileutis, an Israeli biopharmaceutical company, has successfully completed a clinical trial demonstrating the efficacy of its product, Imilac™, in replacing antibiotics in dairy cows during the dry-off period. The trial, conducted across seven dairy farms in Israel, showed that Imilac™ not only substitutes antibiotics but also enhances milk nutritional characteristics, increasing milk yield and improving cow welfare. The product has been patented and is seen as a breakthrough in sustainable dairy farming. Mileutis collaborates with major dairy providers like Yotvata Dairy and Tnuva, aligning with sustainability goals and reducing antibiotic use by up to 90%. This development is expected to positively impact the dairy industry, consumers, and the environment by promoting healthier milk production.","partners":["Yotvata Dairy"],"customers":["Yotvata Dairy","Tnuva"],"investors":null,"confidence":9,"key_topics":["antibiotics","dairy","sustainability","milk yield","animal health"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2zQgGgx14iDUnC6s1rva0zniRSttWobCbtNzNnrp9bKdE8ymyUj1fD","news_summary":"Mileutis’ Clinical Trial Achieves Dramatic Reduction in Antibiotic Use and Enhanced Milk Quality in Dairy Cows","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"te4JVyknLapPLLQBSh5HEG9vb7vtjh3tD9SPDpg27TjsXi1IeAonEm","date":"Feb 8, 2023","link":"https://nocamels.com/2023/02/antibiotic-alternative-today-cows-tomorrow-humans/","source":"nocamels.com","visible":1,"analysis":{"tags":"Antibiotics, Dairy Farming","company":"Mileutis","layoffs":"Not mentioned","summary":"Mileutis, an Israeli bio-pharmaceutical company, has developed a natural alternative to antibiotics for dairy farming. The product, Imilac, uses peptides extracted from milk to boost cows immune systems, reducing the need for antibiotics. The company claims that Imilac is safer and more effective than antibiotics, and could be a game changer for the dairy industry. The product is close to receiving the necessary approvals for widespread use. Despite likely being more expensive than antibiotics, the company argues that it will benefit farmers as cows given Imilac yield more milk.","partners":"Not mentioned","customers":"Dairy Farmers","investors":"Not mentioned","confidence":8,"key_topics":"Antibiotic Resistance, Dairy Farming, Bovine Mastitis, Imilac, Antimicrobial Resistance","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Customers, Partners, Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Partners, Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"8P1ABmvkYLc5A55zDk3UrBRrclWFr0GPvd3SPKu9WTCTSgYn4DQz2z","news_summary":"Antibiotic Alternative: Today Cows, Tomorrow Humans?","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"aIJSsbZBctFr9euag5Jh5p3aKFlxKBY1wcOX77nP8hrtI2RlVPWGxc","date":"Mar 22, 2022","link":"https://www.prnewswire.com/il/news-releases/mileutis-imilac-product-shown-as-a-successful-antibiotic-alternative-in-the-management-of-the-leading-problem-of-the-dairy-industry-mastitis-301506463.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Biopharmaceutical, Antibiotic Alternative","company":"Mileutis","layoffs":"Not mentioned","summary":"Mileutis, an Israeli biopharmaceutical company, has announced that a recent paper published in the Journal of Dairy Science supports the use of its Imilac bovine casein hydrolysate (bCNH) treatment as an alternative to antibiotics for managing Mastitis, a leading problem in the dairy industry. The study found that Imilac is an effective and safe alternative to antibiotics for Mastitis, reduction of Somatic Cell Counts (SCC), and milk enhancement in dairy cows. Mileutis is making significant strides towards combating anti-microbial resistance (AMR), often caused and exacerbated by the overuse of antibiotics.","partners":"Not mentioned","customers":"Farmers and Veterinarians","investors":"Not mentioned","confidence":9,"key_topics":["Mastitis Treatment","Antibiotic Alternative","Imilac Therapy","Dairy Industry","Antimicrobial Resistance"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":["Customers"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"nUad1jHTDaYYSTmMz92yInZV6em5DrfzKpUfO0RNscRT0W7AcdKYNc","news_summary":"Mileutis' Imilac™ product shown as a successful antibiotic alternative in the management of the leading problem of the dairy industry: Mastitis\nLeading journal of dairy sciences recently publishes a study that presents a case for antibiotic alternatives to treat cows at dry-off","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3GaEbACx0LWXcekavNdNXve25Gd16YijK7uANZoX8UI9qkgzdPWt9B","date":"Jan 11, 2021","link":"https://www.dairybusiness.com/mileutis-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference/","source":"www.dairybusiness.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"iWMY4fdGDjOfb7bnMWEPhp31JmedExLL7Yqjfnt0HCDtD7Lr8V9mi6","news_summary":"Mileutis to Present at the 39th Annual J.P. Morgan Healthcare Conference\n","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"58950726-75c7-4213-8883-571d5fe9d266","date":"Oct 19, 2020","link":"https://en.globes.co.il/en/article-israeli-animal-health-co-mileutis-raises-20m-1001346238","source":"en.globes.co.il","visible":1,"analysis":{"tags":"animal health","company":"Mileutis Ltd.","layoffs":null,"summary":"Israeli animal health company Mileutis Ltd. has received a $20 million investment from US life sciences and healthcare investor NovaQuest Capital Management LLC. Mileutis is developing a product to help mitigate the use of antibiotics in animals, specifically addressing bovine mastitis in the dairy industry. The investment will support the continued development and commercialization of Mileutis novel therapies for animal health. Mileutis plans to introduce Imilac, a residue-free peptide, with estimated potential annual revenue of above $1 billion globally. The company aims to revolutionize the way veterinarians manage mastitis and reduce antibiotic use in animal health management.","partners":null,"customers":null,"investors":"NovaQuest Capital Management LLC","confidence":9,"key_topics":["Mileutis","investment","animal health","bovine mastitis","antibiotic resistance"],"date_of_event":"October 19, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$20 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"mHCJyA8gvuPFMxYzL5mptDaChRrIVFri0cWHA9L8uRotfbT4LTa1Wi","news_summary":"Israeli animal health co Mileutis raises $20m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[{"id":"BNzKEmIxIsyYzvho7CqGdit2QX9GVobahSnPvOmmmfBWMOXqvBe6AK","timestamp":"2023-08-14 11:38:10.000000","resources_type":1,"resources_title":"","resources_file_name":"$m2dKSf9X3AySPVyNIV7F5ftuYsBDWib8XAqfgxVwfGh2vj4pCD1gSl.jpg","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$m2dKSf9X3AySPVyNIV7F5ftuYsBDWib8XAqfgxVwfGh2vj4pCD1gSl.jpg","url":"https://storage.googleapis.com/clean-finder-353810/$m2dKSf9X3AySPVyNIV7F5ftuYsBDWib8XAqfgxVwfGh2vj4pCD1gSl.jpg"},{"id":"u19jSKtsRZ0n8khN4s3MxMg9PngQBHIlFqUQ6p65hxhIZyz69Up9le","timestamp":"2023-08-14 11:36:41.000000","resources_type":2,"resources_title":"Mileutis: Where Wisdom and Innovation Meet- Leading the Dairy industry into a Sustainable Future","resources_file_name":"mQ-x6FFnWC8","alt":"Mileutis: Where Wisdom and Innovation Meet- Leading the Dairy industry into a Sustainable Future logo","imageurl":"https://img.youtube.com/vi/mQ-x6FFnWC8/0.jpg","url":"http://youtu.be/mQ-x6FFnWC8"},{"id":"APbE2sG010Pp2uk8HnzmJ9w6BDkZkHRRDx0ilb3drmu2zwokPMSTM2","timestamp":"2023-08-14 11:35:45.000000","resources_type":1,"resources_title":"","resources_file_name":"$lamSjFRnekmE9ORxPllc04xfzvG63KetM5RSu7bEv9VcLD1NBnE6fq.jpg","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$lamSjFRnekmE9ORxPllc04xfzvG63KetM5RSu7bEv9VcLD1NBnE6fq.jpg","url":"https://storage.googleapis.com/clean-finder-353810/$lamSjFRnekmE9ORxPllc04xfzvG63KetM5RSu7bEv9VcLD1NBnE6fq.jpg"},{"id":"rqsuw0TQ1ohTn24cvviUgWSHMT2u5zgvD1Vt6RSktSAF6FvEfI48HV","timestamp":"2023-08-14 11:34:57.000000","resources_type":2,"resources_title":"Mileutis: Leading the dairy industry and animal health into a sustainable future","resources_file_name":"1ks4P1y7RfA","alt":"Mileutis: Leading the dairy industry and animal health into a sustainable future logo","imageurl":"https://img.youtube.com/vi/1ks4P1y7RfA/0.jpg","url":"http://youtu.be/1ks4P1y7RfA"},{"id":"723319a8-d142-4d72-8792-9f19e9c62b78","timestamp":"2020-10-19 10:38:59.000000","resources_type":1,"resources_title":"","resources_file_name":"$Fcz5fCo0hE4417BvQ7mJbtdtmivKADeM3Z0NejJMmFoGCNgmyAUdhY","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$Fcz5fCo0hE4417BvQ7mJbtdtmivKADeM3Z0NejJMmFoGCNgmyAUdhY","url":"https://storage.googleapis.com/clean-finder-353810/$Fcz5fCo0hE4417BvQ7mJbtdtmivKADeM3Z0NejJMmFoGCNgmyAUdhY"},{"id":"d4cbd681-8450-485c-851d-a95e3ac8bb5e","timestamp":"2020-10-15 08:26:26.000000","resources_type":1,"resources_title":"","resources_file_name":"$e9sdOA9YDGz4lIMFYXb3Ob6N6KPIUQpnfz3mJlPBT1TfVyi3qmKQiL","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$e9sdOA9YDGz4lIMFYXb3Ob6N6KPIUQpnfz3mJlPBT1TfVyi3qmKQiL","url":"https://storage.googleapis.com/clean-finder-353810/$e9sdOA9YDGz4lIMFYXb3Ob6N6KPIUQpnfz3mJlPBT1TfVyi3qmKQiL"},{"id":"9624635a-f3e6-4aef-8984-cbc99c0dd573","timestamp":"2020-08-17 12:29:24.000000","resources_type":1,"resources_title":"","resources_file_name":"$vAPIUyvrKZ7Crajl6Q1NXCqJNZLaTlOB4Gy5ehH6VtAYJR9bUoF5wS","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$vAPIUyvrKZ7Crajl6Q1NXCqJNZLaTlOB4Gy5ehH6VtAYJR9bUoF5wS","url":"https://storage.googleapis.com/clean-finder-353810/$vAPIUyvrKZ7Crajl6Q1NXCqJNZLaTlOB4Gy5ehH6VtAYJR9bUoF5wS"}],"tags":["veterinary","chronic-disease","infectious-disease","drug-design","pharmaceuticals","antibiotics","animal-health","livestock","agtech"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0K8KDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B","B2B2C"],"productstage":"Released","products":["Imilac","Milac"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"Undisclosed","totalrounds":2,"fundingstage":"Seed","totalfunding":"$20M","publicinvestors":2,"lastpublicfunding":0,"totalpublicrounds":2,"totalpublicfunding":20000000},"team":[{"name":"David Javier Iscovich, MBA","email":"d.iscovich@mileutis.com","phone":"0526774789","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGn_eQJDA","bounced":false,"claimed":0,"founder":1,"urlname":"david-javier-iscovich-mba","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA3o6JjQgM","position":"Founder  & CEO","last_name":"Iscovich, MBA","claimtoken":"4cadpg61yP0kYaTCRc1rjhohvXjMd1g1bDdONFsRsF17gndarAdTXv","first_name":"David Javier","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/david-javier-iscovich-9157703/","unsubscribed":false,"is_activeuser":0,"additionalemail":"Javier.iscovich@mileutis.com","claimedemaildate":"2024-11-18 15:46:29.000000","initials":"DI","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Jose  Iscovich, MD, MSc","email":"mario.ischovich@mileutis.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPH_6JkKDA","bounced":true,"claimed":0,"founder":1,"urlname":"jose-iscovich-md-msc","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA8eOejgkM","position":"Founder & President","last_name":"Iscovich, MD, MSc","claimtoken":"QSquOwhB2vOZVe20oyfOCd3zrVmBcjcVW0Oh5YQX6WehIqjdw92ou9","first_name":"Jose ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/jose-mario-iscovich-712b43137/","unsubscribed":false,"is_activeuser":0,"additionalemail":"jose.ischovich@mileutis.com","claimedemaildate":"2024-11-18 15:46:33.000000","initials":"JI","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Harel Fred Pradelsky ()","email":"pradelon@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPHA4MYLDA","bounced":false,"claimed":1,"founder":0,"urlname":"hpradelsky","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg3MubxQsM","position":"Director of BD","last_name":"Pradelsky ()","claimtoken":"ddebda3e4138cdd22b611c2495593c6da759dcf206a2ed515b4095ba5cb573e7","first_name":"Harel Fred","picturekey":"$Cg9XGwj8QRsnXBb2qxYtGPH5pGYtdQfX2ZckBu74UGKehuNS0iU5f4","claimeddate":"2019-10-22","linkedinurl":"https://www.linkedin.com/in/harel-fred-pradelsky-%E5%BD%AD%E5%A4%A7%E7%A6%8F-4a6435a0/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-10-22 09:00:16.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$Cg9XGwj8QRsnXBb2qxYtGPH5pGYtdQfX2ZckBu74UGKehuNS0iU5f4","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-01-19T00:00:00.000Z","crunchbaseid":"mileutis","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Sharon Shapira","creator_email":"shapira.sharon2@gmail.com","createdate":"2015-01-27T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"Dfbydw23fiXaBNlWrKWnvIgucmQ46ZDCBlUVlLs7dY7oTPbE8Px97E","date":"May 2024","amount":"Undisclosed","source":"https://www.prnewswire.com/il/news-releases/yotvata-dairy-farm-invests-in-mileutis-to-improve-milk-quality-302156593.html","eventtype":"FundingRoundEvent","investment":[{"name":"Yotvata Dairy","type":"Startup","amount":null,"hidden":true,"country":"Israel","fullurl":"/company_page/yotvata-dairy","logokey":"$RBd5K2cJJEx1AzBJ3iKie3qVqUZWef9w1aqWzNzvdxtfKtv0b4UTBZ.png","tagline":"Yotvata dairy processes some 300,000 liters of milk per day, producing more than 40 different dairy products.","urlname":"/company_page/yotvata-dairy","isisraeli":1,"investorid":"WDwkseeV1zdrWruvEU2QPga0PYyVanPqqXCAd4z0BLszYBsMrq5Ofc","fundingtype":"Startup","leadpartner":null,"investmentid":"SMUMNtowb3VUEwy8WXrQ89kiNdwJbjAJoPSp18kCZYUttuqa4ZT7ey","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$RBd5K2cJJEx1AzBJ3iKie3qVqUZWef9w1aqWzNzvdxtfKtv0b4UTBZ.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD1jYr4Cgw","date":"Oct 2020","amount":"$20M","source":"https://en.globes.co.il/en/article-israeli-animal-health-co-mileutis-raises-20m-1001346238","eventtype":"FundingRoundEvent","investment":[{"name":"NovaQuest Capital Management","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/novaquest-capital-management","logokey":"$Oq28vt8zLYHZNEcYUrOoVH735WeoLSnTwD89gVAVa6r5KVrvVSnr0u","tagline":"","urlname":"/investor_page/novaquest-capital-management","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC1s8WcCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"984a4381-338c-45ce-9346-8e54d479c88f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Oq28vt8zLYHZNEcYUrOoVH735WeoLSnTwD89gVAVa6r5KVrvVSnr0u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":20000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"qoeIYZzxZPcbiuhMkAHvRhwCg2xV1eX1gUfzmBXkrpFpNN9M0oYYqv","hub":"BioGiv","date":"","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NyEhJIKDA","source":"","enddate":"","hub_type":"Entrepreneurship Program","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/biogiv","hub_logokey":"$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","hub_urlname":"/program_page/biogiv","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2004","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Mileutis","logourl":"https://storage.googleapis.com/clean-finder-353810/$E2p8OmkpCPmqBabYQNdLs9XcYBCvK1Hzsdu4cShUW8O2kqsJIHwb3X","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$E2p8OmkpCPmqBabYQNdLs9XcYBCvK1Hzsdu4cShUW8O2kqsJIHwb3X","seoabout":"Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Livestock","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0K8KDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Livestock#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0K8KDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|1:>IndustryClassificationModel/Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA|2:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA/Livestock#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0K8KDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]},{"title":"Agriculture & Food","key":"0-1","path":"IndustryClassificationModel>Agriculture & Food","children":[{"title":"Livestock","key":"0-1-0","path":"IndustryClassificationModel>Agriculture & Food>Livestock"}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Molecules","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Molecules"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Livestock","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0K8KDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Molecules"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Agriculture & Food","Livestock"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"Dfbydw23fiXaBNlWrKWnvIgucmQ46ZDCBlUVlLs7dY7oTPbE8Px97E","date":"May 2024","amount":"Undisclosed","source":"https://www.prnewswire.com/il/news-releases/yotvata-dairy-farm-invests-in-mileutis-to-improve-milk-quality-302156593.html","eventtype":"FundingRoundEvent","investment":[{"name":"Yotvata Dairy","type":"Startup","amount":null,"hidden":true,"country":"Israel","fullurl":"/company_page/yotvata-dairy","logokey":"$RBd5K2cJJEx1AzBJ3iKie3qVqUZWef9w1aqWzNzvdxtfKtv0b4UTBZ.png","tagline":"Yotvata dairy processes some 300,000 liters of milk per day, producing more than 40 different dairy products.","urlname":"/company_page/yotvata-dairy","isisraeli":1,"investorid":"WDwkseeV1zdrWruvEU2QPga0PYyVanPqqXCAd4z0BLszYBsMrq5Ofc","fundingtype":"Startup","leadpartner":null,"investmentid":"SMUMNtowb3VUEwy8WXrQ89kiNdwJbjAJoPSp18kCZYUttuqa4ZT7ey","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$RBd5K2cJJEx1AzBJ3iKie3qVqUZWef9w1aqWzNzvdxtfKtv0b4UTBZ.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD1jYr4Cgw","date":"Oct 2020","amount":"$20M","source":"https://en.globes.co.il/en/article-israeli-animal-health-co-mileutis-raises-20m-1001346238","eventtype":"FundingRoundEvent","investment":[{"name":"NovaQuest Capital Management","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/novaquest-capital-management","logokey":"$Oq28vt8zLYHZNEcYUrOoVH735WeoLSnTwD89gVAVa6r5KVrvVSnr0u","tagline":"","urlname":"/investor_page/novaquest-capital-management","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC1s8WcCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"984a4381-338c-45ce-9346-8e54d479c88f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Oq28vt8zLYHZNEcYUrOoVH735WeoLSnTwD89gVAVa6r5KVrvVSnr0u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":20000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}